Skip to main content
Top
Published in: Rheumatology International 10/2009

01-08-2009 | Case Report

A “silent” course of normotensive scleroderma renal crisis: case report and review of the literature

Authors: Hadim Akoglu, Gokhan Kadir Atılgan, Ramazan Ozturk, Ezgi Coskun Yenigun, Ipek Isık Gonul, Ali Rıza Odabas

Published in: Rheumatology International | Issue 10/2009

Login to get access

Abstract

Scleroderma renal crisis (SRC) is a complication of systemic sclerosis characterized by the sudden onset of accelerated arterial hypertension, followed by progressive renal failure. Rarely, patients with SRC may be normotensive on presentation. These patients have poorer prognosis and higher mortality rates than those with hypertensive SRC. This is partly explained by the insidious course of normotensive SRC leading to delayed diagnosis and treatment. Normotensive patients also seem to be less responsive to current treatment modalities. Since available data on etiology, pathogenesis, and risk factors of the disease are inadequate, no effective therapy has been established to date. We report a patient with diffuse cutaneous scleroderma who developed SRC during his hospitalization. The patient remained normotensive and had an insidious course until oliguria and signs of hypervolemia occurred. Etiology, pathogenesis, risk factors, diagnosis, treatment modalities and prognosis of normotensive SRC are also discussed through previously published reports.
Literature
3.
go back to reference Traub YM, Shapiro AP, Rodnan GP et al (1983) Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 62(6):335–352. doi:10.1097/00005792-198311000-00001 Traub YM, Shapiro AP, Rodnan GP et al (1983) Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 62(6):335–352. doi:10.​1097/​00005792-198311000-00001
4.
go back to reference Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA Jr (2005) Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32(4):649–655PubMed Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA Jr (2005) Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32(4):649–655PubMed
9.
go back to reference Villaverde M, González A, Orellano P, Lafage M (2003) Normotensive scleroderma renal crisis. Medicina (B Aires) 63(1):49–50 Villaverde M, González A, Orellano P, Lafage M (2003) Normotensive scleroderma renal crisis. Medicina (B Aires) 63(1):49–50
10.
go back to reference Kohno K, Katayama T, Majima K et al (2000) A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment. Clin Nephrol 53(6):479–482PubMed Kohno K, Katayama T, Majima K et al (2000) A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment. Clin Nephrol 53(6):479–482PubMed
11.
go back to reference Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC (1974) The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 53(1):1–46CrossRef Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC (1974) The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 53(1):1–46CrossRef
12.
go back to reference Shapiro CB, Lerner NE, Ackad AS, Abramson RG, Stein RM (1977) Malignant hypertension and uremia in scleroderma: efficacy of nephrectomy and hemodialysis. Clin Nephrol 8(1):321–323PubMed Shapiro CB, Lerner NE, Ackad AS, Abramson RG, Stein RM (1977) Malignant hypertension and uremia in scleroderma: efficacy of nephrectomy and hemodialysis. Clin Nephrol 8(1):321–323PubMed
15.
go back to reference Zakopoulos NA, Kotsis VT, Gialafos EJ et al (2003) Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 21(2):199–204PubMed Zakopoulos NA, Kotsis VT, Gialafos EJ et al (2003) Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 21(2):199–204PubMed
16.
go back to reference Winograd J, Schimmel DH, Palubinskas AJ (1976) The spotted nephrogram of renal scleroderma. AJR Am J Roentgenol 126(4):734–738PubMed Winograd J, Schimmel DH, Palubinskas AJ (1976) The spotted nephrogram of renal scleroderma. AJR Am J Roentgenol 126(4):734–738PubMed
18.
go back to reference Kovalchik MT, Guggenheim SJ, Silverman MH, Robertson JS, Steigerwald JC (1978) The kidney in progressive systemic sclerosis: a prospective study. Ann Intern Med 89(6):881–887PubMed Kovalchik MT, Guggenheim SJ, Silverman MH, Robertson JS, Steigerwald JC (1978) The kidney in progressive systemic sclerosis: a prospective study. Ann Intern Med 89(6):881–887PubMed
19.
go back to reference Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41(9):1613–1619. doi:10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-OPubMedCrossRef Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41(9):1613–1619. doi:10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-OPubMedCrossRef
20.
go back to reference Kobayashi H, Nishimaki T, Kaise S et al (1999) Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis. Clin Rheumatol 18(5):425–427. doi:10.1007/s100670050132 PubMedCrossRef Kobayashi H, Nishimaki T, Kaise S et al (1999) Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis. Clin Rheumatol 18(5):425–427. doi:10.​1007/​s100670050132 PubMedCrossRef
23.
go back to reference DeMarco PJ, Weisman MH, Seibold JR et al (2002) Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose d penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum 46(11):2983–2989. doi:10.1002/art.10589 PubMedCrossRef DeMarco PJ, Weisman MH, Seibold JR et al (2002) Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose d penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum 46(11):2983–2989. doi:10.​1002/​art.​10589 PubMedCrossRef
24.
go back to reference Sharnoff JG, Carideo HL, Stein ID (1951) Cortisone-treated scleroderma; report of a case with autopsy findings. J Am Med Assoc 145(16):1230–1232PubMed Sharnoff JG, Carideo HL, Stein ID (1951) Cortisone-treated scleroderma; report of a case with autopsy findings. J Am Med Assoc 145(16):1230–1232PubMed
25.
go back to reference Clements PJ, Hurwitz EL, Wong WK et al (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43(11):2445–2454. doi:10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-QPubMedCrossRef Clements PJ, Hurwitz EL, Wong WK et al (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43(11):2445–2454. doi:10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-QPubMedCrossRef
26.
go back to reference Haviv YS, Safadi R (1998) Normotensive scleroderma renal crisis: case report and review of the literature. Ren Fail 20(5):733–736PubMedCrossRef Haviv YS, Safadi R (1998) Normotensive scleroderma renal crisis: case report and review of the literature. Ren Fail 20(5):733–736PubMedCrossRef
28.
go back to reference Guerini S, Cavazzana I, Venturelli C et al (2007)Renal involvement in systemic sclerosis. G Ital Nefrol 24(4):295–310 Guerini S, Cavazzana I, Venturelli C et al (2007)Renal involvement in systemic sclerosis. G Ital Nefrol 24(4):295–310
29.
30.
go back to reference Kamen DL, Wigley FM, Brown AN (2006) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma-a different kind of renal crisis. J Rheumatol 33(9):1886–1888PubMed Kamen DL, Wigley FM, Brown AN (2006) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma-a different kind of renal crisis. J Rheumatol 33(9):1886–1888PubMed
32.
go back to reference Arnaud L, Huart A, Plaisier E et al (2007) ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the “normotensive scleroderma renal crisis”. Clin Nephrol 68(3):165–170PubMed Arnaud L, Huart A, Plaisier E et al (2007) ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the “normotensive scleroderma renal crisis”. Clin Nephrol 68(3):165–170PubMed
33.
go back to reference Martínez Ara J, Picazo ML, Torre A, Pascual D, Díaz Rodríguez C, Riñón C (2000) Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement. Nefrologia 20(4):383–386 Martínez Ara J, Picazo ML, Torre A, Pascual D, Díaz Rodríguez C, Riñón C (2000) Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement. Nefrologia 20(4):383–386
34.
go back to reference Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113(5):352–357PubMed Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113(5):352–357PubMed
35.
go back to reference Steen VD, Medsger TA Jr (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133(8):600–603PubMed Steen VD, Medsger TA Jr (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133(8):600–603PubMed
37.
go back to reference Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444. doi:10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-UPubMedCrossRef Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437–2444. doi:10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-UPubMedCrossRef
Metadata
Title
A “silent” course of normotensive scleroderma renal crisis: case report and review of the literature
Authors
Hadim Akoglu
Gokhan Kadir Atılgan
Ramazan Ozturk
Ezgi Coskun Yenigun
Ipek Isık Gonul
Ali Rıza Odabas
Publication date
01-08-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0807-1

Other articles of this Issue 10/2009

Rheumatology International 10/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.